Onderneming Bausch Health Companies Inc. Toronto S.E.
Aandelen
BHC
CA0717341071
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
10,32 CAD | +2,89% | +5,20% | -2,92% |
Vakgebied
Aantal werknemers: 20 270
Verkoop per activiteit
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Bausch + Lomb/International
47,3
%
| 4 905 | 46,4 % | 5 596 | 47,3 % | +14,07% |
Salix
25,7
%
| 2 721 | 25,7 % | 3 037 | 25,7 % | +11,61% |
International
12,2
%
| 1 286 | 12,2 % | 1 446 | 12,2 % | +12,38% |
Diversified
10,8
%
| 1 273 | 12,0 % | 1 273 | 10,8 % | -0,04% |
Solta Medical
4,0
%
| 391 | 3,7 % | 468 | 4,0 % | +19,92% |
Verkoop per regio
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States and Puerto Rico
59,3
%
| 6 296 | 59,5 % | 7 010 | 59,3 % | +11,35% |
Other
11,5
%
| 1 155 | 10,9 % | 1 365 | 11,5 % | +18,17% |
China
5,0
%
| 538 | 5,1 % | 595 | 5,0 % | +10,70% |
Canada
4,2
%
| 457 | 4,3 % | 494 | 4,2 % | +8,10% |
Mexico
3,7
%
| 359 | 3,4 % | 435 | 3,7 % | +20,95% |
Poland
3,6
%
| 362 | 3,4 % | 431 | 3,6 % | +18,96% |
France
2,4
%
| 264 | 2,5 % | 289 | 2,4 % | +9,29% |
Japan
2,2
%
| 260 | 2,5 % | 262 | 2,2 % | +0,56% |
Germany
1,7
%
| 191 | 1,8 % | 205 | 1,7 % | +7,20% |
Russia
1,7
%
| 236 | 2,2 % | 200 | 1,7 % | -15,23% |
United Kingdom
1,4
%
| 150 | 1,4 % | 169 | 1,4 % | +12,69% |
South Korea
1,1
%
| 100 | 0,9 % | 126 | 1,1 % | +25,22% |
Spain
1,1
%
| 109 | 1,0 % | 124 | 1,1 % | +13,55% |
Italy
1,0
%
| 99 | 0,9 % | 116 | 1,0 % | +17,32% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
John Barresi
DFI | Director of Finance/CFO | 51 | 24-05-22 |
Chief Operating Officer | - | - | |
Tage Ramakrishna
CTO | Chief Tech/Sci/R&D Officer | 49 | 01-01-11 |
Investor Relations Contact | - | 19-06-17 | |
Human Resources Officer | - | 01-01-19 | |
Jeff Hartness
LAW | General Counsel | - | - |
Dennis Asharin
PRN | Corporate Officer/Principal | - | 01-01-07 |
Treasurer | 48 | - | |
Corporate Officer/Principal | 59 | 08-08-16 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Power
BRD | Director/Board Member | 67 | 01-08-08 |
John Paulson
CHM | Chairman | 68 | 01-06-17 |
Steven Miller
BRD | Director/Board Member | 35 | 17-03-21 |
Richard Mulligan
BRD | Director/Board Member | 69 | 06-05-22 |
Brett Icahn
BRD | Director/Board Member | 44 | 17-03-21 |
Sarah Kavanagh
BRD | Director/Board Member | 67 | 22-07-16 |
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
Amy Wechsler
BRD | Director/Board Member | 54 | 14-06-16 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 360 989 744 | 352 090 604 ( 97,53 %) | 0 | 97,53 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
BAUSCH + LOMB CORPORATION 88.45% | 310 449 643 | 88.45% | 4 507 728 816 $ |
Bedrijfsgegevens
Bausch Health Cos., Inc.
2150 St. Elzéar Boulevard West
H7L 4A8, Laval
+514 744 6792
http://www.bauschhealth.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
Bausch & Lomb India Pvt Ltd.
Bausch & Lomb India Pvt Ltd. Electronic ComponentsElectronic Technology Part of Bausch Health Cos., Inc., Bausch & Lomb India Pvt Ltd. is a company that specializes in providing soft contact lenses and lens care products. The company was founded in 2000. The company is based in Gurgaon, India. The Indian company's main focus is to help people see better and live better by providing soft contact lenses that are specifically shaped to focus light into the retina of the eye. Additionally, Bausch + Lomb offers a complete line of soft contact lens care products designed to make the lens wearing experience healthy and comfortable. |
Electronic Components
|
Medical Specialties
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+61,53% | 856 mld. | |
+38,95% | 631 mld. | |
-3,66% | 359 mld. | |
+15,06% | 325 mld. | |
+9,18% | 297 mld. | |
+5,89% | 234 mld. | |
+16,53% | 226 mld. | |
+15,67% | 177 mld. | |
+2,47% | 165 mld. |